Less than 1% of patients on semaglutide or tirzepatide develop dependence—far lower than opioids. Find out why GLP‑1 drugs stay safe and how that shapes obesity treatment.
miriam096
Posted on • Originally published at nexusbase.site
Unmask Glp‑1 / Weight‑Loss Drugs Addiction Risk <1%
For further actions, you may consider blocking this person and/or reporting abuse
Top comments (0)